Catalent
CTLT
#1496
Rank
HK$89.52 B
Marketcap
HK$493.24
Share price
0.00%
Change (1 day)
43.87%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Catalent (CTLT) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$47.90 Billion

According to Catalent's latest financial reports the company's total liabilities are HK$47.90 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Catalent - Total liabilities on balance sheet (from 2013 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30HK$48.33 B7.45%
2022-06-30HK$44.98 B19.76%
2021-06-30HK$37.55 B13.47%
2020-06-30HK$33.10 B8.75%
2019-06-30HK$30.43 B12.6%
2018-06-30HK$27.03 B26.84%
2017-06-30HK$21.31 B11.88%
2016-06-30HK$19.04 B-1.87%
2015-06-30HK$19.41 B-27.66%
2014-06-30HK$26.83 B2.97%
2013-06-30HK$26.06 B-3.73%
2012-06-30HK$27.07 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$2.60 B-94.56%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$4.19 B-91.25%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$62.81 B 31.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
HK$2.49 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA